Intensive antihypertensive treatment to the new lower blood pressure targets

Current Hypertension Reports

Volumn 1, Issue 4, 1999, Pages 313-319

  Elliott, William J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GOVERNMENT; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; HYPERTENSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; MANAGED CARE PROGRAMS; QUALITY OF HEALTH CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0033170554     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0039-0     Document Type: Article

References (32)

1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997, 157: 2413-2446.
2. Stewart IMDG: Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979, 1: 861-865.
3. McCloskey LW, Psaty BM, Koepsell TD, Aagaar GN: Level of blood pressure and risk of myocardial infarction among treated hypertensive patients. Arch Intern Med 1992, 152: 513-520.
4. Cruickshank JM, Thorpe JM, Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1987, 1: 581-584.
5. Farnett L, Mulrow CD, Linn WD, et al.: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991, 265: 489-495.
6. Fletcher AE, Bulpitt CJ: How far should blood pressure be lowered? N Engl J Med 1992, 326: 251-254.
7. Hansson L: The BBB study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in "well-treated" hypertensive patients. Behandla Blodtryck Battre. Blood Pressure 1994, 3: 248-254.
8. Hansson L, Zanchetti A, Julius S, et al.: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351: 1755-1762.
9. Wiklund I, Halling K, Ryden-Bergsten T, Fletcher A: Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) Study. Blood Pressure 1997, 6: 357-364.
10. Kaplan N: J-curve not burned off by HOT Study. Hypertension Optimal Treatment [editorial]. Lancet 1998, 351: 1758-1749.
11. The Systolic Hypertension in the Elderly Program Cooperative Study Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991, 265: 3255-3264.
12. Staessen JA, Fagard R, Thijs L, et al.: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350: 757-764.
13. Liu L, Wang J, Gong L, et al.: Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998, 16: 1823-1829.
14. Toumilehto J, Rastenyte D, Birkenhäger WH, et al.: Effects of calcium channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999, 340: 677-684.
15. Curb DB, Pressel SL, Cutler JA, et al.: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996, 276: 1886-1892.
16. Alderman M: Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993, 119: 329-335.
17. Lever AF, Ramsay LE: Treatment of hypertension in the elderly. J Hypertens 1995, 13: 571-579.
18. Chatellier G, Ménard J: The absolute risk as a guide to influence the treatment decision-making process in mild hypertension. J Hypertens 1997, 15: 217-219.
19. Klahr S, Levey AS, Beck GJ, et al.: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994, 330: 877-884.
20. Lazarus JM, Bourgoignie JJ, Buckalew VM, et al.: Achievement and safety of a low blood pressure goal in chronic renal disease: the Modification of Diet in Renal Disease Study Group. Hypertension 1997, 29: 641-650.
21. Jacobson HR, Striker GE: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 1995, 25: 153-156.
22. Turner R, Holman R, Stratton I, et al.: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. United Kingdom Prospective Diabetes Study Group. BMJ 1998, 317: 707-713.
23. Elliott WJ, Weir DR, Black HR: Cost-effectiveness of the new treatment goal of JNC VI for diabetics and the renallyimpaired [abstract]. Am J Hypertens 1998, 11:8A.
24. Raikou M, Gray A, Briggs A, et al.: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. United Kingdom Prospective Diabetes Study Group. BMJ 1998, 317: 720-726.
25. Weinstein MC, Seigel JE, Gold MR, et al.: Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996, 276: 1253-1258.
26. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 1998, 21(suppl):S23-S31.
27. Siegel D, Lopez J: Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA 1997, 278: 1745-1748.
28. National Committee for Quality Assurance (NCQA): HEDIS 3.0, v. 1. In Washington, DC: National Committee for Quality Assurance; 1997.
29. Grimaldi PL: New HEDIS means more information about HMOs. J Health Care Financ 1997, 23: 40-50.
30. Bodenheimer T: The American health care system - the movement for improved quality in health care. N Engl J Med 1999, 340: 488-492.
31. Epstein AM: Rolling down the runway: the challenges ahead for quality report cards. JAMA 1998, 279: 1691-1696.
32. Chassin MR, Galvin RW: The urgent need to improve health care quality. JAMA 1998, 280: 1000-1005.